Mokhir A - Search Results

1

N-Alkylaminoferrocene-Based Prodrugs Targeting Mitochondria of Cancer Cells.

Reshetnikov V, Özkan HG, Daum S, Janko C, Alexiou C, Sauer C, Heinrich MR, Mokhir A. Reshetnikov V, et al. Among authors: mokhir a. Molecules. 2020 May 29;25(11):2545. doi: 10.3390/molecules25112545. Molecules. 2020. PMID: 32486084 Free PMC article.

2

Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells.

Marzenell P, Hagen H, Sellner L, Zenz T, Grinyte R, Pavlov V, Daum S, Mokhir A. Marzenell P, et al. Among authors: mokhir a. J Med Chem. 2013 Sep 12;56(17):6935-44. doi: 10.1021/jm400754c. Epub 2013 Aug 26. J Med Chem. 2013. PMID: 23931109

3

Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity.

Daum S, Chekhun VF, Todor IN, Lukianova NY, Shvets YV, Sellner L, Putzker K, Lewis J, Zenz T, de Graaf IA, Groothuis GM, Casini A, Zozulia O, Hampel F, Mokhir A. Daum S, et al. Among authors: mokhir a. J Med Chem. 2015 Feb 26;58(4):2015-24. doi: 10.1021/jm5019548. Epub 2015 Feb 9. J Med Chem. 2015. PMID: 25633601 Free article.

4

Pharmacological effect of aminoferrocene in mice with L1210 leukemia.

Chekhun VF, Mokhir A, Daum S, Todor IN, Lukianova NY, Shvets YV, Burlaka AP. Chekhun VF, et al. Among authors: mokhir a. Exp Oncol. 2015 Jun;37(2):120-5. Exp Oncol. 2015. PMID: 26112939

5

Activity of aminoferrocene-based prodrugs against prostate cancer.

Schikora M, Reznikov A, Chaykovskaya L, Sachinska O, Polyakova L, Mokhir A. Schikora M, et al. Among authors: mokhir a. Bioorg Med Chem Lett. 2015 Sep 1;25(17):3447-50. doi: 10.1016/j.bmcl.2015.07.013. Epub 2015 Jul 11. Bioorg Med Chem Lett. 2015. PMID: 26206503

6

Cancer-Specific, Intracellular, Reductive Activation of Anticancer Pt^IV Prodrugs.

Reshetnikov V, Daum S, Mokhir A. Reshetnikov V, et al. Among authors: mokhir a. Chemistry. 2017 Apr 27;23(24):5678-5681. doi: 10.1002/chem.201701192. Epub 2017 Apr 5. Chemistry. 2017. PMID: 28319647

7

[1,10]Phenanthroline based cyanine dyes as fluorescent probes for ribonucleic acids in live cells.

Kovalska V, Kuperman M, Varzatskii O, Kryvorotenko D, Kinski E, Schikora M, Janko C, Alexiou C, Yarmoluk S, Mokhir A. Kovalska V, et al. Among authors: mokhir a. Methods Appl Fluoresc. 2017 Oct 24;5(4):045002. doi: 10.1088/2050-6120/aa8510. Methods Appl Fluoresc. 2017. PMID: 28790236

8

Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs.

Daum S, Reshetnikov MSV, Sisa M, Dumych T, Lootsik MD, Bilyy R, Bila E, Janko C, Alexiou C, Herrmann M, Sellner L, Mokhir A. Daum S, et al. Among authors: mokhir a. Angew Chem Int Ed Engl. 2017 Dec 4;56(49):15545-15549. doi: 10.1002/anie.201706585. Epub 2017 Nov 9. Angew Chem Int Ed Engl. 2017. PMID: 28994179

9

Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution.

Daum S, Babiy S, Konovalova H, Hofer W, Shtemenko A, Shtemenko N, Janko C, Alexiou C, Mokhir A. Daum S, et al. Among authors: mokhir a. J Inorg Biochem. 2018 Jan;178:9-17. doi: 10.1016/j.jinorgbio.2017.08.038. Epub 2017 Sep 15. J Inorg Biochem. 2018. PMID: 29028541

10

A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.

Reshetnikov V , Arkhypov A , Julakanti PR , Mokhir A . Reshetnikov V , et al. Among authors: mokhir a. Dalton Trans. 2018 May 15;47(19):6679-6682. doi: 10.1039/c8dt01458b. Dalton Trans. 2018. PMID: 29708261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page